## Note
nid: 1499999109081
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::30_Tisagenlecleucel, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#Physeo::11_Pathology::07_General_Pathology::09_Carcinogenesis, #AK_Step1_v11::#SketchyPharm::Immunology-&-Biochemistry-Pharmacology::Immuno-stimulants-&-Biochemistry-Pharmacology::Enzyme-Replacement-Therapy,Gene-Therapy,and-Cystic-Fibrosis-Therapy, #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^HighYield::2-RelativelyHighYield
markdown: false

### Text
<div>
  <div>
    The main acute side effect of <b>Tisagenlecleucel</b> is
    {{c1::<b>Cytokine Release Syndrome</b>}} while a potential long
    term risk is the potential for {{c2::<b>insertional
    mutagenesis</b>}}
  </div>
</div>

### Extra
<i>- the main symptoms of cytokine storm are a high fever, extreme
fatigue, nausea; potential to be fatal; also occurs in GVHD, ARDS,
Sepsis</i>
<div>
  <i>- because Tisagenlecleucel is generated by using a</i>
  <i>retrovirus, concerns that it could modify a protoconcogene /
  tumor suppressor are warranted</i>
</div>
<div>
  <i><img src="paste-172245368438785.jpg"></i>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_3.png"></a>
</div>

### Additional Resources


### One by one

